DMDavid Metcalfe

David Metcalfe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Metcalfe has a total of 427 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Salim

    Center for Surgery and Public Health (CSPH), One Brigham Circle, Boston, Massachusetts; Division of Trauma, Burn, and Surgical Critical Care, Brigham & Women's Hospital, Boston, Massachusetts

    16 shared publications
  • Daniel Christopher Perry

    Trauma and Orthopaedics Department, Alder Hey Children's Hospital, Liverpool, UK

    14 shared publications
  • Cheryl K. Zogg

    Yale School of Medicine, New Haven, Connecticut, USA

    13 shared publications
  • Adil H. Haider

    Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Harvard T. H. Chan School of Public Health, Boston, Massachusetts

    10 shared publications
  • Olubode A. Olufajo

    Department of Surgery, Howard University College of Medicine, Washington, DC

    10 shared publications
  • Matthew L Costa

    Kadoorie Institute for Trauma, Emergency and Critical Care, University of Oxford, Oxford, Oxfordshire, UK

    8 shared publications

Latest Publications

  • Open Access

    Systematic assessment of the medical utility of radiology and diagnostic Artificial Intelligence in fracture detection (SAMURAI-fracture): a protocol for a multicentre cluster-randomised controlled trial

    by Alex Novak, James Vaz, Abdala T Espinosa Morgado, Sally Beer, Katrina Nash, Ashar Asif, Michael Lundemann, David Metcalfe, Matthew L Costa, Nick Woznitza, et al.

    Introduction: Fracture misdiagnosis is a common diagnostic error in emergency departments (EDs) and minor injury units (MIUs), leading to poor patient outcomes, unnecessary treatments and significant healthcare costs. Artificial intelligence (AI)-assisted fracture detection tools are now available for use in radiology workflows; however, the impact of these technologies on patient outcomes, experiences and overall care pathways in the real-world clinical setting is limited. Methods and analysis: We will conduct a prospective cluster randomised cross-over trial over a 6-month period, assessing the impact of an AI-assisted fracture detection tool in EDs and MIUs across 4 healthcare Trusts in the UK. Patients aged over 2 years old undergoing a plain film radiography for a suspected fracture as part of routine clinical care will be eligible for study enrolment. The trial will deploy Radiobotics’ RBfracture, a CE-approved AI-assisted medical device software for fracture detection at each site for 6 months. Randomisation will be at a cluster-level; a site will be randomised to begin with ‘AI on’ or ‘AI off’ for a month, followed by alternating active status each month for the remaining 5 months. The primary outcome will evaluate the incidence of ‘inappropriate healthcare contacts’ among patients receiving imaging for suspected fractures. This composite metric encompasses inappropriate referrals to fracture clinics, repeated hospital attendances and subsequent follow-up communications regarding missed fractures. The rates of these measures will be compared in the ‘AI on’ versus ‘AI off’ stages. Secondary outcomes will include patient-reported outcomes, clinician surveys, a predefined health economic evaluation assessing cost-effectiveness and budget impact and the diagnostic performance of the algorithm. Ethics and dissemination: The study has received ethical approval from the South Central—Oxford Research Ethics Committee (Reference: 25/SC/0252, approval date: 23 October 2025), and subsequently from the Health Research Authority (IRAS 3 57 391-A). The results of this study will be presented at relevant scientific conferences and peer-reviewed publications will be disseminated on wider public forums such as traditional and social media. Registration details: This is an ongoing, actively recruiting trial ( ISRCTN23087950 ). Recruitment began in January 2026 and will run for 6 months at each site, with per-patient follow-up of 30 days and subsequent data analysis. This manuscript describes protocol version 1.1. The full protocol and statistical analysis plan are available from the corresponding author on request and will be deposited on the study’s public repository ( https://github.com/Jason-L-Oke/SAMURAI ) prior to publication of results. Trial registration number: ISRCTN23087950 .

  • Point-of-care ultrasound-guided regional anaesthesia: pericapsular nerve group (PENG) block for patients with hip fracture

    by Riccardo Maffeis, Santi Di Pietro, David Metcalfe, Stefano Perlini

    A plain radiograph of the pelvis confirms the clinical suspicion of a left-sided femoral neck fracture (figure 1).

  • Journal update monthly top five

    by Kieran Johnstone, Mohamed Gomaa Kamel, Johnathan Goves, Hanya El-Geresy, Richard Mifsud, Alex Novak, David Metcalfe, Liam Barrett

  • Open Access

    Research priorities in lower leg soft-tissue injuries in older adults: a modified Delphi study (PRIME)

    by Shiraz Q. Shafi, Simon M. Graham, David Metcalfe, Clare Greenwood, David J. Beard, Matthew L. Costa, Justin C.R. Wormald

  • Open Access

    Cauda equina syndrome early recognition study

    by Kylea Draper- Kadoorie, David Metcalfe

  • Open Access

    The protocol for a multicentre prospective randomized noninferiority trial of surgical reduction versus non-surgical casting for displaced distal radius fractures in children

    by Daniel C. Perry, Juul Achten, James Mason, Daphne Kounail, Nicolas Nicolaou, David Metcalfe, Mark Lyttle, Elizabeth Tutton, Duncan Appelbe, Phoebe Gibson, et al.

    Aims: The remarkable capacity for distal radius fractures in children to remodel raises questions about the necessity and extent of the intervention required to achieve anatomical alignment. The British Society of Children’s Orthopaedic Surgery prioritized this uncertainty as one of their most important research questions. This is the protocol for a randomized, controlled, multicentre, prospective, noninferiority trial of non-surgical casting versus surgical reduction for severely displaced fractures of the distal radius in children: the Children’s Radius Acute Fracture Fixation Trial.Methods: Children aged four to ten years old inclusive, who have sustained a severely displaced distal radius fracture, are eligible to take part. Baseline function using the Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Score, pain measured using the Wong-Baker FACES Pain Scale, and quality of life (QoL) assessed with the EuroQol five-dimension questionnaire for younger participants will be collected. Each patient will be randomly allocated (1:1), stratified using a minimization algorithm by centre, fracture type at presentation (completely off-ended or incompletely off-ended), fracture location (metaphyseal or physeal), and age group (four to six years or seven to ten years) to either a regimen of non-surgical casting or surgical reduction.Conclusion: At six weeks, and three, six, and 12 months, data on function, pain, QoL, cosmesis, and satisfaction with care will be collected. After completion of the main phase of the study, patients will be followed up for a further two years. Up to one year after randomization, the main outcomes plus data on complications, resource use, and school absence will be collected. The primary outcome is the PROMIS Upper Extremity Score at three months post-randomization. All data will be obtained through electronic questionnaires completed by the participants and/or parents/guardians.Cite this article: Bone Jt Open 2025;6(5):560–568.


  • Can non-contrast CT exclude subarachnoid haemorrhage?

    by David Metcalfe, Jeff Perry

  • Improving clinician interpretation of emergency skeletal radiographs

    by David Metcalfe, Sarim Ather, Alex Novak

  • Open Access

    Non-invasive versus arterial pressure monitoring in the pre-hospital critical care environment: a paired comparison of concurrently recorded measurements

    by Yani Perera, James Raitt, Kurtis Poole, David Metcalfe, Asher Lewinsohn

    Background: Blood pressure monitoring is important in the pre-hospital management of critically ill patients. Non-invasive blood pressure (NIBP) measurements are commonly used but the accuracy of standard oscillometric cuff devices may be affected by extremes of physiology and adverse conditions (e.g. vibration) during transport. This study aimed to quantify the accuracy of NIBP measurements amongst patients requiring pre-hospital critical care. Methods: A retrospective cohort study was undertaken using data from patients treated by a pre-hospital critical team between 1st May 2020 and 30th April 2023 that had NIBP measured concurrently with invasive blood pressure (IBP) arterial manometry. An acceptable difference was determined a priori to be < 20mmHg for systolic blood pressure (SBP) and diastolic blood pressure (DBP), and < 10mmHg for mean arterial pressure (MAP). The primary outcome was “pairwise agreement”, i.e. the proportion of paired observations that fell within this range of acceptability. Bland-Altman plots were constructed together with 95% limits of agreement to visualise differences between pairs of data. Associations with patient age, reason for critical care, transport status, haemodynamic shock, severe hypertension, and arterial catheter position were explored in univariate analyses and by fitting multivariable logistic regression models. Results: There were 2,359 paired measurements from 221 individual patients with a median age of 57. The most frequent reason for transport was cardiac arrest (79, 35.7%). Bland-Altman analyses suggested unacceptably wide limits of agreement with NIBP overestimating both SBP and MAP during hypotension and underestimating these values during hypertension. Haemodynamic shock (SBP < 90mmHg) was independently associated with reduced pairwise agreement for SBP (adjusted odds ratio [aOR] 0.52, 95% CI 0.35 to 0.77), DBP (aOR 0.65, 95% CI 0.42 to 0.99) and MAP (aOR 0.53, 95% CI 0.36 to 0.78) and severe hypertension (SBP > 160mmHg) with reduced pairwise agreement for SBP (aOR 0.17, 95% CI 0.11 to 0.27). There was no association between patient transport and agreement between the methods for SBP, DBP, or MAP. Conclusions: Non-invasive blood pressure measurements are often inaccurate in the pre-hospital critical care setting, particularly in patients with haemodynamic instability. Clinicians should be cautious when interpreting NIBP measurements and consider direct arterial pressure monitoring when circumstances allow.